Carboxylesterase 2 is downregulated in colorectal cancer following progression of the disease

Cancer Investigation

Volumn 26, Issue 2, 2008, Pages 178-181

  Tang, Xiaobo ^a   Wu, Hong ^b   Wu, Zhenghua ^a   Wang, Guiyu ^a   Wang, Zhigang ^a   Zhu, Daling ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

Colorectal cancer; Human carboxylesterase 2; Staging

Indexed keywords

CARBOXYLESTERASE; CARBOXYLESTERASE 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; DOWN REGULATION; ENZYME BLOOD LEVEL; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CAMPTOTHECIN; CARBOXYLESTERASE; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA TOPOISOMERASES, TYPE I; DOWN-REGULATION; HUMANS; IMMUNOGLOBULIN G; MICE; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 38949142258     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701560786     Document Type: Article

References (12)

1. Xu, G.; Zhang, W.; Ma, M.K.; McLeod, H.L. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin. Cancer Res. 2002, 8, 2605-2611.
2. Guichard, S.; Terret, C.; Hennebelle, I.; Lochon, I.; Chevreau, P.; Fretigny, E. Irinotecan converting carboxylesterase and topoisomerase activities in tumor and normal colon and liver tissues. Br. J. Cancer.1999, 80, 364-370.
3. Sanghani, S.P.; Quinney, S.K.; Fredenburg, T.B.; Sun, Z.; Davis, W.I.; Murry, D.J.; et al. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin Cancer Res. 2003, 9, 4983-4991.
4. Gao, J.; Gao, Y.; Ju, Y.; Yang, J.; Wu, Q.; Zhang, J.; et al. Proteomics-based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins. Proteomics. 2005, 1-11.
5. Wu, Z.; Tang, X.; Wang, Z.; Ji, H.; Yu, L.; Liu, H.; Zhu, D. Preparation and characterization of monoclonal antibody against human carboxylesterase 2, J. Cell and Molecular Immunology. 2007, 23, 148-151.
6. Bradford, M.M. A rapid and sensitive method for the quantitation of microgramquantities of protein utilizing the principle of protein-dye binding. Anal. Bio. 1976, 72, 248-254.
7. Danks, M.K.; Morton, C.L.; Krull, E.J.; Cheshire, P.J.; Richmond, L.B.; Naeve, C.W. et al. Comparison of activation of irinotecan by rabbit and human carboxylesterase for use in enzyme/prodrug therapy. Clin Cancer Res. 1999, 5, 917-924.
8. Khanna, R.; Morton, C.L.; Danks, M.K.; Potter, P.M. Proficient metabolism of iriotecan by a human intestinal carboxylesterase. Cancer Res. 2000, 60, 4725-4728.
9. Humerickhouse, R.; Lohrbach, K.; Li, L.; Borson, W.F.; Dolan, M.E. Characterization of irinotecan hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res. 2000, 60, 1189-1192.
10. Potter, P.M.; Wolverton, J.S.; Morton, C.L.; Whipple, D.O.; Danks, M.K. In situ subcellular localization of epitope-tagged human and rabbit carboxylesterase. Cytometry. 1998, 32, 223-232.
11. Satoh, T.; Hosokawa, M.; Atsumi, R.; Suzuki, W.; Hakusui, H.; Nagai, E. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. Biol Pharm Bull. 1994, 17, 662-664.
12. Yan, B.; Matoney, L.; Yang, D. Human carboxylesterases in term placenta: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms. Placenta. 1999, 20, 599-607.